<DOC>
	<DOCNO>NCT02032784</DOCNO>
	<brief_summary>Our hypothesis prophylactic administration 5 day Octreotide follow EMR ampullectomy patient duodenal ampullary adenoma great equal 10mm .</brief_summary>
	<brief_title>Prophylactic Octreotide Prevent Post Duodenal EMR Ampullectomy Bleeding</brief_title>
	<detailed_description>Inclusion Criteria : Duodenal ampullary adenoma great equal 10mm . Duodenal ampullary adenoma suitable endoscopic mucosal resection . Medically fit anesthesia , endoscopy , EMR Able provide Informed Consent 18 year old , male female Exclusion criterion : Duodenal ampullary adenoma &lt; 10mm Duodenal ampullary adenoma suitable endoscopic mucosal resection Medically unfit anesthesia , endoscopy , EMR Unable provide Informed Consent Less 18 year old Allergy Octreotide</detailed_description>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Duodenal ampullary adenoma great equal 10mm Duodenal ampullary adenoma suitable endoscopic mucosal resection Medically fit anesthesia , endoscopy , EMR Able provide Informed Consent 18 year old , male female Duodenal ampullary adenoma &lt; 10mm Duodenal ampullary adenoma suitable endoscopic mucosal resection Medically unfit anesthesia , endoscopy , EMR Unable provide inform consent Less 18 year old Allergy Octreotide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>